Table 1.
Correlation between Clinical Factors and SUVmax, SUVmean, MTV and TLG in 73 LAPC Patients
| Clinical Factors | Cases | SUVmax | SUVmean | ||||
|---|---|---|---|---|---|---|---|
| M (P25, P75) | z Value or χ2 Value |
P Value | M (P25, P75) | z Value or χ2 Value |
P Value | ||
| Age (yrs) | − 0.387 | 0.699 | −0.392 | 0.695 | |||
| ≤ 68 | 38 | 7.0 (6.1, 9.7) | 4.1 (3.4, 5.7) | ||||
| >68 | 35 | 6.6 (5.3, 10.1) | 3.8 (3.0, 5.5) | ||||
| Presence of DM | −0.533 | 0.594 | −0.232 | 0.816 | |||
| No | 58 | 6.9 (5.9, 10.0) | 4.0 (3.2, 5.7) | ||||
| Yes | 15 | 6.8 (5.8, 8.5) | 4.0 (3.0, 5.3) | ||||
| ECOG | 0.838a | 0.658 | 1.742a | 0.418 | |||
| 0 | 13 | 6.7 (6.4, 9.9) | 4.0 (3.5, 5.4) | ||||
| 1 | 32 | 7.1 (5.5, 11.3) | 4.3 (2.9, 6.7) | ||||
| 2 | 28 | 6.6 (5.2, 9.1) | 3.7 (3.0, 5.2) | ||||
| N Stage | −2.184 | 0.029 | −1.974 | 0.048 | |||
| 0 | 40 | 6.7 (5.6, 8.1) | 3.7 (3.1, 4.4) | ||||
| 1 | 33 | 8.6 (5.9, 11.2) | 4.9 (3.3, 6.5) | ||||
| Position | −0.709 | 0.478 | −0.746 | 0.456 | |||
| Head | 51 | 6.8 (6.0, 10.2) | 4.1 (3.4, 5.5) | ||||
| Body/ Tail | 22 | 7.0 (5.28, 9.6) | 3.8 (3.0, 5.7) | ||||
| The longest diameter (cm) | −1.353 | 0.176 | −1.054 | 0.292 | |||
| ≤ 3.7 | 40 | 6.7 (5.8, 8.4) | 3.9 (3.1, 5.1) | ||||
| > 3.7 | 33 | 7.3 (6.0, 11.1) | 4.2 (3.1, 6.6) | ||||
| CA 19–9 (ng/mL) | −0.590 | 0.555 | −0.497 | 0.619 | |||
| ≤ 321.6 | 37 | 6.7 (5.7, 9.6) | 4.0 (3.0, 5.4) | ||||
| > 321.6 | 36 | 7.1 (5.8, 10.0) | 4.1 (3.3, 5.7) | ||||
| Clinical Factors | Cases | MTV (cm3) | TLG (g) | ||||
| M (P25, P75) |
z Value or χ2 Value |
P Value | M (P25, P75) |
z Value or χ2 Value |
P Value | ||
| Age (yrs) | −0.961 | 0.337 | −0.939 | 0.348 | |||
| ≤ 68 | 38 | 11.3 (6.5, 19.8) | 48.2 (29.6, 75.4) | ||||
| >68 | 35 | 13.2 (7.3, 27.1) | 58.1 (33.9, 98.4) | ||||
| Presence of DM | −0.608 | 0.543 | 0.000 | 1.000 | |||
| No | 58 | 11.8 (7.3, 20.0) | 49.0 (34.2, 85.2) | ||||
| Yes | 15 | 15.9 (5.2, 35.5) | 62.2 (25.4, 146.3) | ||||
| ECOG | 0.331b | 0.847 | 0.063b | 0.969 | |||
| 0 | 13 | 12.2 (7.0, 20.5) | 48.7 (32.3, 83.5) | ||||
| 1 | 32 | 10.5 (5.6, 23.7) | 51.0 (29.9, 88.9) | ||||
| 2 | 28 | 12.6 (9.2, 25.9) | 49.4 (34.0, 93.9) | ||||
| N Stage | −1.336 | 0.182 | −2.682 | 0.007 | |||
| 0 | 40 | 12.1 (6.3, 15.7) | 45.6 (27.9, 64.4) | ||||
| 1 | 33 | 13.9 (7.0, 35.6) | 67.8 (37.9, 117.1) | ||||
| Position | −1.455 | 0.146 | −1.353 | 0.176 | |||
| Head | 51 | 11.7 (6.7, 5.9) | 46.8 (28.6, 82.1) | ||||
| Body/ Tail | 22 | 20.2 (7.8, 28.5) | 61.1 (39.7, 99.1) | ||||
| The longest diameter (cm) | −1.596 | 0.110 | −2.111 | 0.035 | |||
| ≤ 3.7 | 40 | 10.0 (5.6, 18.9) | 41.7 (26.0, 77.5) | ||||
| > 3.7 | 33 | 13.9 (8.4, 24.2) | 64.7 (40.0, 91.3) | ||||
| CA 19–9 (ng/mL) | −0.083 | 0.934 | −0.535 | 0.593 | |||
| ≤ 321.6 | 37 | 12.6 (7.5, 17.9) | 48.7 (32.2, 80.6) | ||||
| > 321.6 | 36 | 10.5 (6.4, 25.2) | 55.4 (30.7, 92.5) | ||||
LAPC locally advanced pancreatic cancer; SUV standardized uptake value; MTV metabolic tumor volume; TLG total lesion glycolysis; DM diabetes mellitus; ECOG Eastern Cooperative Oncology Group
a, b: χ2 Value
*: P < 0.05